Program

2019 Scientific Program

Planning of the AF2019 scientific program is currently underway, and will be published here once finalized. Please check back periodically for updates. For a point of reference, the program below is from AF2018.

 


 

 

REGISTRATION and BADGE PICK-UP

 

Wednesday, January 10, 2018, Noon - 6:30 p.m.

Thursday, January 11, 2018, 6:30 a.m. - 6 p.m.

Friday, January 12, 2018, 6:30 a.m. - 6 p.m.

 

EXHIBIT FLOOR

 

Opens Thursday, January 11, 2018, 9 a.m. - 4:30 p.m.

 

 

 

THURSDAY, JANUARY 11, 2018
 

Morning Scientific Session

 

 

7 - 7:10 a.m.          

 

WELCOME AND OVERVIEW OF THE 23RD ANNUAL AF SYMPOSIUM

Jeremy Ruskin, MD

 

 

7:10 - 9:20 a.m.

 

PATHOPHYSIOLOGY, RISK FACTORS AND GENETICS

Moderators: Natalia Trayanova, PhD and Stanley Nattel, MD

All lectures 15 minutes and 5-minute Q&A

 

Aging, Inflammation and Atrial Fibrillation

Jose Jalife, MD

 

Fibrosis and AF: Insights from Patient-Specific Computational Simulations and Implications for AF Ablation

Natalia Trayanova, PhD

 

Lean Body Mass as a Common Denominator Connecting Treatable Risk Factors to AF: Evidence and Potential Significance

Stanley Nattel, MD

 

Linking AF Genetics to New Mechanisms: Are AF Associated Genes Potential Drug Targets?

Patrick Ellinor, MD, PhD

 

Novel Upstream Targets for AF from Genomics/Transcriptomics

Mina Chung, MD

 

Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Jose Jalife, MD

 

 

9:20 - 9:50 a.m.

 

BREAK, EXHIBITS and ABSTRACTS

 

 

9:50 a.m. - Noon

 

STROKE PREVENTION IN AND SCREENING FOR ATRIAL FIBRILLATION

Moderators: Elaine Hylek, MD, MPH and Daniel Singer, MD

All lectures 15 minutes and 5-minute Q&A

 

Current Status of Screening for AF: Frequency, Significance and Limitations of AHREs; How Much Should We Screen?

John Camm, MD

 

Real-World Data On NOACs and AF: How Is It Generated and What Does It Mean? and Future Trials on Stroke Prevention in AF

Daniel Singer, MD

 

Factor XIa Inhibitors: A New Class of Anticoagulants with Less Thrombus and Less Bleeding

Elaine Hylek, MD, MPH

 

Understanding High Intracranial Hemorrhage Risk: Biomarkers and Challenges in Management

M. Edip Gurol, MD

 

Can Anticoagulation Be Stopped After AF Ablation?

Yes: Francis Marchlinski, MD

No: Elaine Hylek, MD, MPH

(Each speaker 10 minutes; additional comments during panel discussion)

 

Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: John Camm, MD

 

 

Noon - 1:15 p.m.  

 

LUNCH, EXHIBITS and ABSTRACTS

 

 

 

THURSDAY, JANUARY 11, 2018

 

Afternoon Scientific Session

 

 

1:15 - 3:35 p.m.

 

LEFT ATRIAL APPENDAGE CLOSURE AND CASE TRANSMISSIONS

Moderators: Dhanunjaya Lakkireddy, MD and Jacqueline Saw, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each

 

LAA Closure: Current State of the Art and Future Directions

Jacqueline Saw, MD

 

Case Transmissions - LAA Closure Procedures

Moderator: Vivek Reddy, MD

 

LAA Closure with ICE Guidance

Claudio Tondo, MD, PhD - Milan, Italy

 

New Technology for LA Appendage Closure

Tom De Potter, MD - Aalst, Belgium

 

Anticoagulation After LAA Closure: State of the Art and Future Directions

Vivek Reddy, MD

 

Role of Octreotide in LAA Closure in Patients with GI Bleeding

Dhanunjaya Lakkireddy, MD

 

FDA Perspectives on Left Atrial Appendage Occlusion Trials: Transforming Data into Evidence

Andrew Farb, MD

 

 

3:35 - 4:05 p.m.

 

BREAK, EXHIBITS and ABSTRACTS

 

 

4:05 - 4:55 p.m.

 

IF I HAD PERMANENT AF AND PREVIOUS INTRACRANIAL HEMORRHAGE I WOULD CHOOSE:

Moderator: David Keane, MD, PhD

Each lecture 10 minutes

 

Endocardial LAA Closure

Jacqueline Saw, MD

 

Epicardial LAA Closure

Dhanunjaya Lakkireddy, MD

 

Apixaban 5mg B.I.D.

Peter Kowey, MD

 

Panel and Audience Q&A and Discussion - All Faculty (20 minutes)

Moderator: David Keane, MD, PhD

 

 

4:55 - 6:15 p.m.

 

CHALLENGING CASES IN AF MANAGEMENT I: ANTIARRHYTHMIC DRUGS, ANTICOAGULATION, AND CLINICAL DECISION MAKING

Panel and Audience Discussion (10 minutes per case)

Moderator: Eric Prystowsky, MD

Panel: Mina Chung, MD, Peter Kowey, MD, Eric Prystowsky, MD and Jeremy Ruskin, MD 

 

 

6:15 p.m.

 

ADJOURN

 

 


 

 

FRIDAY, JANUARY 12, 2018

 

Morning Scientific Session

 

 

7 - 9:10 a.m.

 

PHYSIOLOGY AND EXPERIMENTAL INSIGHTS: IMPLICATIONS FOR AF ABLATION

Moderator: Ulrich Schotten, MD, PhD

All lectures 15 minutes and 5-minute Q&A

 

A Cascade of Accelerating Rotors Precedes Stabilization of Early AF

Jose Jalife, MD

 

Atrial Myocardial Fiber Orientation In Human Autopsy Hearts: Implications for Transmural Breakthrough, 3-D Reentry and the Role of the LAA

David Keane, MD, PhD

 

3-D Computer Modelling of Endo-Epicardial Dissociation and Transmural Conduction in AF Using High Density Mapping 

Ulrich Schotten, MD, PhD

 

Atrial Fibrosis: Distribution, Extent and Clinical Characteristics as Predictors of Outcome of AF Ablation - Time for a Fundamental Change in Strategy?

Hans Kottkamp, MD

 

Atrial Fibrosis: A New Marker for Major Cardiovascular Events

Nassir Marrouche, MD

 

Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Ulrich Schotten, MD, PhD

 

 

9:10 - 9:40 a.m.

 

BREAK, EXHIBITS and ABSTRACTS

 

 

9:40 a.m. - 12:40 p.m.

 

MECHANISM-GUIDED ABLATION OF ATRIAL FIBRILLATION AND CASE TRANSMISSIONS

Moderators: Pierre Jais, MD and David Wilber, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each

 

Relation Between Rotors and Anatomical Obstacles During Atrial Fibrillation

Sanjiv Narayan, MD, PhD

 

Identification of AF Drivers and Endpoints for Ablation Using Multielectrode Catheters in Persistent AF

Michel Haissaguerre, MD

 

Complex Atrial Tachycardias Unmasked by Ultra High Density Mapping

Pierre Jais, MD

 

Beyond PV Isolation: Randomized Clinical Trials of Adjunctive Ablation Strategies for Persistent Atrial Fibrillation (AMAZE, DECAAF II, REAFFIRM)

David Wilber, MD

 

In What Types of AF Should LA Appendage Ablation Be Considered? Evidence and Patient Selection

Andrea Natale, MD

 

Case Transmissions - Techniques for Left Atrial Appendage Electrical Isolation as Adjunctive Therapy to PV Isolation in Persistent AF

 

Bradley Knight, MD - Chicago, IL

 

Rodney Horton, MD and Andrea Natale, MD - Austin, TX

 

New Approaches to Modulation of the Autonomic Nervous System in AF: Visualization and Ablation of Ganglionated Plexi

Evgeny Pokushalov, MD, PhD

 

 

12:40 - 1:55 p.m.

 

LUNCH, EXHIBITS and ABSTRACTS

 

 

 

FRIDAY, JANUARY 12, 2018

 

Afternoon Scientific Session

 

 

1:55 - 3:55 p.m.

 

NEW TECHNOLOGIES, LATE BREAKING TRIALS, FIRST REPORT INVESTIGATIONS IN AF ABLATION AND CASE TRANSMISSIONS

Moderator: Moussa Mansour, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each

 

Real-Time Lesion Formation and Gap Detection During Ablation of Atrial Fibrillation Using Novel Electro-Anatomical Dielectric Mapping System: 12 Month Follow-Up

Evgeny Pokushalov, MD, PhD

 

Case Transmission - Lesion Assessment

Petr Neuzil, MD and Vivek Reddy, MD - Prague, Czech Republic

 

Case Transmission - New Techniques for Esophageal Protection

Kevin Heist, MD, PhD, Conor Barrett, MD, and Moussa Mansour, MD - Boston, MA

 

HEAT-AF: First Clinical Study On Effects A New Infrared Thermography Probe for Esophageal Protection

Thomas Deneke, MD

 

Randomized Evaluation of Atrial Fibrillation Treatment with Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM): Interim Analysis

Johannes Brachman, MD

 

 

3:55 - 4:25 p.m.

 

BREAK, EXHIBITS and ABSTRACTS

 

 

4:25 - 6:35 p.m.

 

NEW TECHNOLOGIES FOR AF ABLATION (continued)

Moderator: Karl-Heinz Kuck, MD

 

Prospective Non-Randomized FDA IDE Trial on a New Technology for Localizing Rotors and Focal Drivers of AF

Vivek Reddy, MD

 

Global Multi-Electrode Contact Mapping and Ablation of AF with a Single Catheter - First Human Experience

Hans Kottkamp, MD

 

Temperature Controlled Irrigated RF Ablation: Technology and Results

Moussa Mansour, MD

 

New RF Balloon Technologies for AF Ablation - Results of Multicenter Clinical Studies

Karl-Heinz Kuck, MD

 

Pulsed Electric Field Ablation: Preclinical Studies Assessing Safety and Efficacy

David Haines, MD

 

Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Karl-Heinz Kuck, MD

 

6:35 p.m.

 

ADJOURN

 

 


 

 

SATURDAY, JANUARY 13, 2018

 

Morning Scientific Session

 

 

7 - 9:30 a.m.

 

CLINICAL TRIALS, GUIDELINES AND REGULATORY ISSUES IN AF MANAGEMENT

Moderator: Douglas Packer, MD

All lectures 15 minutes and 5-minute Q&A

 

Clinical Trials of New Technologies in AF Ablation: 2018 Update 

Hugh Calkins, MD

 

2017 HRS/EHRA/ECAS/APHRS/SOLAECE Consensus Document on AF Ablation: Implications for Patient Care and Research 

Hugh Calkins, MD

 

Clinical Trials in AF Ablation: What Will CABANA Show and Will It Matter?

Douglas Packer, MD

 

Regulatory Challenges and Future Directions in AF Ablation Device Development and Evaluation

Mark Fellman

 

Does AF Ablation Improve Mortality in Congestive Heart Failure: New Insights from the CASTLE-AF Trial

Nassir Marrouche, MD

 

Ablation Strategies in Patients with AF and Congestive Heart Failure: Practical Considerations and Outcomes

Luigi Di Biase, MD, PhD

 

Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Douglas Packer, MD

 

 

9:30 - 10 a.m.

 

BREAK AND EXHIBITS

 

 

10 a.m. - 12:10 p.m.

 

EVOLVING STRATEGIES TO IMPROVE THE SUCCESS AND SAFETY OF AF ABLATION

Moderator: Young-Hoon Kim, MD, PhD

All lectures 15 minutes and 5-minute Q&A

 

Characteristics and Ablation Outcomes in Early Onset AF: Role of One-Year Follow-Up Atrial MR Imaging

Young-Hoon Kim, MD, PhD

 

High Power Short Duration RF Ablation: Safety and Efficacy - Multicenter Experience

Pierre Jais, MD

 

What To Do After Three Failed AF Ablations?

Andrea Natale, MD

 

How to Improve the Speed and Efficiency AF Ablation While Maintaining Safety and Effectiveness

Rob Patrawala, MD

 

Big Data, Social Media and Monitoring: Optimizing Patient Outcomes in AF

Kevin Campbell, MD

 

Panel and Audience Q&A and Discussion - All Faculty (30 Minutes)

Moderator: Young-Hoon Kim, MD, PhD

 

 

12:10 - 12:30 p.m.

 

ALBERT L. WALDO OUTSTANDING ABSTRACT AWARD AND PRESENTATION

Moderators: Jeremy Ruskin, MD and Albert Waldo, MD

 

 

12:30 - 1:45 p.m. 

 

LUNCH AND EXHIBITS

 

 

 

SATURDAY, JANUARY 13, 2018

 

Afternoon Scientific Session

 

 

1:45 – 3:15 p.m.

 

CHALLENGING CASES IN AF MANAGEMENT II: CATHETER ABLATION AND LEFT ATRIAL APPENDAGE CLOSURE

Panel and Audience Discussion (10 minutes per case)

Moderator: Pierre Jais, MD 

Panel: Pierre Jais, MD, Young-Hoon Kim, MD, PhD, Moussa Mansour, MD, Andrea Natale, MD and Vivek Reddy, MD

 

 

3:15 p.m.

 

ADJOURN

 

CME Certification Requests

AF Symposium 
Information Regarding CME Certificate Requests
 
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com.  On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 11472.  Upon registering and successfully completing activity evaluation, your certificate will be made available immediately.
 
 
 
*Please note for ANCC credit, you must complete an evaluation for each day of the symposium.

Newsletter Archive

Faculty Presentation Submission Portal

Course Directors

Jeremy N. Ruskin, MD
Moussa Mansour, MD

Vivek Reddy, MD

David Keane, MD, PhD
Pierre Jais, MD

 

REGISTRATION OPENS IN AUGUST

 

January 24-26, 2019

Hyatt Regency Orlando
Orlando, Florida